In addition, NMOSD patients had higher CSF NLRP3 levels compared with MS patients.237 These findings indicate that levels of NLRP3 in CSF could be a potential diagnostic marker in NMOSD and MS. The gene discussed is NLRP3; the disease is myeloid sarcoma.